- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:46 | Bavarian Nordic A/S: Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business | 330 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, November 1, 2025 - Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement, announced... ► Artikel lesen | |
| 10:01 | Samstag Meldung zu EVOTEC SE - Jetzt wird's brisant! | 50 | Maximilian Berger | ||
| 02:30 | Arch Biopartners Inc: Arch Biopartners acquisition of Lipdro Therapeutics | 1 | Stockwatch | ||
| 01:42 | Onco-Innovations Ltd: Onco-Innovations sets out updates from the past months | 7 | Stockwatch | ||
| 00:06 | Cybin Inc (2): Cybin closes $175-million (U.S.) offering | 5 | Stockwatch | ||
| Fr | Onco-Innovations stellt Update für Aktionäre im Anschluss an Cboe Canada Investor Spotlight bereit | 1.895 | IR-WORLD | Schwerpunkt auf US-Strategie
Vancouver, Kanada - 31. Oktober 2025 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (FWB: W1H, WKN: A3EKSZ) ("Onco" oder das "Unternehmen")... ► Artikel lesen | |
| Fr | $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today | 2 | Benzinga.com | ||
| Fr | Onco-Innovations Limited: Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight | 373 | ACCESS Newswire | Focus on U.S. Strategy VANCOUVER, BC / ACCESS Newswire / October 31, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide... ► Artikel lesen | |
| Fr | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Plan | 70 | PR Newswire | PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help... ► Artikel lesen | |
| Fr | IDEXX upgraded to buy at Stifel on Dx analyzer recurring revenue growth | 3 | Seeking Alpha | ||
| Fr | Protagenic Therapeutics reicht Klage zur Rückabwicklung der Übernahme von Phytanix Bio ein | 1 | Investing.com Deutsch | ||
| Fr | Medifast Q3 2025 Earnings Preview | 3 | Seeking Alpha | ||
| Fr | Protagenic Therapeutics, Inc.\new - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Lummus, InnoVent Partner to Scale Tire Recycling | 1 | Mexico Business News | ||
| Fr | Earnings Outlook For Medifast | 2 | Benzinga.com | ||
| Fr | Karyopharm Therapeutics Earnings Preview | 2 | Benzinga.com | ||
| Fr | What's Next: Biodesix's Earnings Preview | 2 | Benzinga.com | ||
| Fr | Amgen Announces 2025 Fourth Quarter Dividend | 159 | PR Newswire | THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the... ► Artikel lesen | |
| Fr | INTENSITY THERAPEUTICS, INC. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Cybin raises $175 million in direct offering to fund clinical programs | 4 | Investing.com |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| ONCO-INNOVATIONS | 3 | - | +0,99 % | Onco-Innovations gibt Abschluss von Privatplatzierung bekannt | Nicht zur Weitergabe an US-Nachrichtendienste oder Verbreitung in den Vereinigten Staaten bestimmt
Vancouver, Kanada - 27. Oktober 2025 / IRW-Press / Onco-Innovations Limited (CBOE... ► Artikel lesen | ||
| AMGEN | 2 | 27 | +0,12 % | Amgen Announces 2025 Fourth Quarter Dividend | THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the... ► Artikel lesen | ||
| FIBROBIOLOGICS | 2 | 6 | +5,39 % | FibroBiologics, Inc.: FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients ... ► Artikel lesen | ||
| CELLECTIS | 2 | 3 | -4,49 % | Cellectis to Report Third Quarter Financial Results on November 7, 2025 | |||
| MEDIFAST | 2 | 2 | +1,05 % | Medifast Q3 2025 Earnings Preview | |||
| PROTAGENIC THERAPEUTICS | 2 | 2 | -4,14 % | Protagenic Therapeutics reicht Klage zur Rückabwicklung der Übernahme von Phytanix Bio ein | |||
| CYBIN | 2 | - | +1,59 % | Cybin Inc (2): Cybin closes $175-million (U.S.) offering | |||
| GINKGO BIOWORKS | 2 | - | 0,00 % | Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture | BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer... ► Artikel lesen | ||
| EVOTEC | 1 | 44 | -0,59 % | Evotec mit starkem Kaufsignal - Aktie vor neuer Rallye? | Die Anteile des Hamburger Wirkstoffforschers festigen zum Wochenauftakt ihre Position oberhalb von 7 Euro. Dafür gibt es nach Unternehmensnews gute Gründe. Evotec-Aktie: Es war in diesem Jahr auch schon... ► Artikel lesen | ||
| IDEXX LABORATORIES | 1 | 15 | -0,14 % | IDEXX upgraded to buy at Stifel on Dx analyzer recurring revenue growth |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| NANOREPRO AG | 1,685 | 4,50 | +167 % | 1 | - | - | |||
| MARINOMED BIOTECH AG | 20,400 | 51 | +150 % | 1 | - | - | |||
| BIONTECH SE ADR | 90,40 | 117,06 | +29 % | 2 | 2 | - | |||
| EVOTEC SE | 7,054 | 8,97 | +27 % | 3 | 1 | - | |||
| QIAGEN NV | 40,760 | 50 | +23 % | 5 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 206,20 | 231,67 | +12 % | 6 | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .